Key Points
-
P bodies are discrete cytoplasmic domains in which proteins that are involved in mRNA degradation, translational repression, mRNA surveillance and RNA-mediated gene silencing colocalize.
-
Key features of P bodies have been conserved throughout evolution. First, P-body assembly is dependent on RNA — treating cells with ribonucleases leads to the dispersion of P bodies. Second, the size and number of P bodies depends on the fraction of mRNAs that are undergoing decapping. Blocking mRNA decay at an early stage (for example, by preventing deadenylation) leads to P-body loss, whereas blocking decapping leads to an increase in the size and number of P bodies. Last, P bodies are dispersed by drugs that stabilize polysomes (for example, cycloheximide) and are enhanced by drugs that release ribosomes from mRNA (for example, puromycin). Therefore, mRNAs must exit the translation cycle to enter into P bodies.
-
The available evidence indicates that mRNA decay, translational repression and mRNA silencing can take place in P bodies. However, it is still unclear whether the integrity of P bodies is required for these processes to occur or whether P bodies arise as a consequence of these activities.
-
P bodies share common components with other messenger ribonucleoprotein (mRNP) granules that are present in stressed mammalian cells (stress granules), in polarized cells such as neurons, and during oogenesis in diverse organisms (polar granules).
Abstract
Post-transcriptional processes have a central role in the regulation of eukaryotic gene expression. Although it has been known for a long time that these processes are functionally linked, often by the use of common protein factors, it has only recently become apparent that many of these processes are also physically connected. Indeed, proteins that are involved in mRNA degradation, translational repression, mRNA surveillance and RNA-mediated gene silencing, together with their mRNA targets, colocalize within discrete cytoplasmic domains known as P bodies. The available evidence indicates that P bodies are sites where mRNAs that are not being translated accumulate, the information carried by associated proteins and regulatory RNAs is integrated, and their fate — either translation, silencing or decay — is decided.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Wilusz, C. J. & Wilusz, J. Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet. 20, 491–497 (2004).
Fasken, M. B. & Corbett, A. H. Process or perish: quality control in mRNA biogenesis. Nature Struct. Mol. Biol. 12, 482–488 (2005).
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J. & Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20, 515–524 (2006).
Bashkirov, V. I., Scherthan, H., Solinger, J. A., Buerstedde, J. M. & Heyer, W. D. A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates. J. Cell Biol. 136, 761–773 (1997).
van Dijk, E. et al. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21, 6915–6924 (2002).
Ingelfinger, D., Arndt-Jovin, D. J., Luhrmann, R. & Achsel, T. The human LSm1–7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8, 1489–1501 (2002).
Lykke-Andersen, J. Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol. Cell. Biol. 22, 8114–8121 (2002).
Sheth, U. & Parker, R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300, 805–808 (2003). Provides the first evidence that proteins that are involved in mRNA decapping and 5′→3′ mRNA degradation localize in cytoplasmic foci in S. cerevisiae . These foci were consequently called mRNA-processing bodies or P bodies.
Cougot, N., Babajko, S. & Seraphin, B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 165, 31–40 (2004). Shows that factors that are involved in 5′→3′ mRNA decay localize in cytoplasmic foci in human cells. These foci are sites of mRNA decay that disappear on treatment with transcriptional inhibitors.
Eystathioy, T. et al. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell 13, 1338–1351 (2002). First description of the localization of GW182 in cytoplasmic foci, which were later shown to be P bodies. See also reference 11.
Eystathioy, T. et al. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 9, 1171–1173 (2003).
Yang, W. H., Yu, J. H., Gulick, T., Bloch, K. D. & Bloch, D. B. RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA 12, 547–554 (2006).
Yu, J. H., Yang, W. H., Gulick, T., Bloch, K. D. & Bloch, D. B. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 11, 1795–1802 (2005).
Fenger-Gron, M., Fillman, C., Norrild, B. & Lykke-Andersen, J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell 20, 905–915 (2005). References 13 and 14 show that an uncharacterized human protein, called Ge-1, RCD-8 or Hedls, localizes to P bodies. Reference 14 shows that Hedls is part of a large protein complex that comprises the decapping enzyme DCP2 and the decapping co-activators DCP1, RCK/p54 and EDC3.
Bloch, D. B., Gulick, T., Bloch, K. D. & Yang, W. H. Processing body autoantibodies reconsidered. RNA 12, 707–709 (2006).
Albrecht, M. & Lengauer, T. Novel Sm-like proteins with long C-terminal tails and associated methyltransferases. FEBS Lett. 569, 18–26 (2004).
Anantharaman, V. & Aravind, L. Novel conserved domains in proteins with predicted roles in eukaryotic cell-cycle regulation, decapping and RNA stability. BMC Genomics 5, 45 (2004).
Yang, Z. et al. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J. Cell Sci. 117, 5567–5578 (2004).
Teixeira, D., Sheth, U., Valencia-Sanchez, M. A., Brengues, M. & Parker, R. Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA 11, 371–382 (2005).
Brengues, M., Teixeira, D. & Parker, R. Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 310, 486–489 (2005).
Sheth, U. & Parker, R. Targeting of aberrant mRNAs to cytoplasmic processing bodies. Cell 125, 1095–1109 (2006).
Andrei, M. A. et al. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 11, 717–727 (2005).
Ferraiuolo, M. A. et al. A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay. J. Cell Biol. 170, 913–924 (2005).
Parker, R. & Song, H. The enzymes and control of eukaryotic mRNA turnover. Nature Struct. Mol. Biol. 11, 121–127 (2004).
Houseley, J., LaCava, J. & Tollervey, D. RNA-quality control by the exosome. Nature Rev. Mol. Cell Biol. 7, 529–539 (2006).
Kshirsagar, M. & Parker, R. Identification of Edc3p as an enhancer of mRNA decapping in Saccharomyces cerevisiae. Genetics 166, 729–739 (2004).
Tharun, S., Muhlrad, D., Chowdhury, A. & Parker, R. Mutations in the Saccharomyces cerevisiae LSM1 gene that affect mRNA decapping and 3′ end protection. Genetics 170, 33–46 (2005).
Bonnerot, C., Boeck, R. & Lapeyre, B. The two proteins Pat1p (Mrt1p) and Spb8p interact in vivo, are required for mRNA decay, and are functionally linked to Pab1p. Mol. Cell. Biol. 20, 5939–5946 (2000).
Bouveret, E., Rigaut, G., Shevchenko, A., Wilm, M. & Seraphin, B. A Sm-like protein complex that participates in mRNA degradation. EMBO J. 19, 1661–1671 (2000).
Tharun, S. et al. Yeast Sm-like proteins function in mRNA decapping and decay. Nature 404, 515–518 (2000).
Tharun, S. & Parker, R. Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p–7p complex on deadenylated yeast mRNAs. Mol. Cell 8, 1075–1083 (2001).
Coller, J. & Parker, R. General translational repression by activators of mRNA decapping. Cell 122, 875–886 (2005).
Chu, C. Y. & Rana, T. M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol. 4, e210 (2006). Reports the involvement of RCK/p54 in miRNA-mediated gene silencing and its function as a general translational repressor. The authors show for the first time that silencing by siRNAs is not affected in cells in which P bodies are dispersed by depletion of LSm1.
Behm-Ansmant, I. et al. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20, 1885–1898 (2006).
Kedersha, N. et al. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 169, 871–884 (2005). Describes commonalities and differences as well as a dynamic link between P bodies and stress granules.
Conti, E. & Izaurralde, E. Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. Curr. Opin. Cell Biol. 17, 316–325 (2005).
Lejeune, F. & Maquat, L. E. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr. Opin. Cell Biol. 17, 309–315 (2005).
Amrani, N., Sachs, M. S. & Jacobson, A. Early nonsense: mRNA decay solves a translational problem. Nature Rev. Mol. Cell Biol. 7, 415–425 (2006).
Cao, D. & Parker, R. Computational modeling and experimental analysis of nonsense-mediated decay in yeast. Cell 113, 533–545 (2003).
Mitchell, P. & Tollervey, D. An NMD pathway in yeast involving accelerated deadenylation and exosome-mediated 3′→5′ degradation. Mol. Cell 11, 1405–1413 (2003).
Chen, C. Y. & Shyu, A. B. Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway. Mol. Cell. Biol. 23, 4805–4813 (2003).
Couttet, P. & Grange, T. Premature termination codons enhance mRNA decapping in human cells. Nucleic Acids Res. 32, 488–494 (2004).
Lejeune, F., Li, X. & Maquat, L. E. Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol. Cell 12, 675–687 (2003).
Gatfield, D. & Izaurralde, E. Nonsense-mediated messenger RNA decay is initiated by endonucleolytic cleavage in Drosophila. Nature 429, 575–578 (2004).
Unterholzner, L. & Izaurralde, E. SMG7 acts as a molecular link between mRNA surveillance and mRNA decay. Mol. Cell 16, 587–596 (2004).
Fukuhara, N. et al. SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway. Mol. Cell 17, 537–547 (2005).
Anders, K. R., Grimson, A. & Anderson, P. SMG-5, required for C. elegans nonsense-mediated mRNA decay, associates with SMG-2 and protein phosphatase 2A. EMBO J. 22, 641–650 (2003).
Ohnishi, T. et al. Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. Mol. Cell 12, 1187–1200 (2003).
Gatfield, D., Unterholzner, L., Ciccarelli, F. D., Bork, P. & Izaurralde, E. Nonsense-mediated mRNA decay in Drosophila: at the intersection of the yeast and mammalian pathways. EMBO J. 22, 3960–3970 (2003).
He, F. & Jacobson, A. Upf1p, Nmd2p, and Upf3p regulate the decapping and exonucleolytic degradation of both nonsense-containing mRNAs and wild-type mRNAs. Mol. Cell. Biol. 21, 1515–1530 (2001).
Rehwinkel, J., Behm-Ansmant, I., Gatfield, D. & Izaurralde, E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11, 1640–1647 (2005).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Filipowicz, W. RNAi: the nuts and bolts of the RISC machine. Cell 122, 17–20 (2005).
Lingel, A. & Sattler, M. Novel modes of protein–RNA recognition in the RNAi pathway. Curr. Opin. Struct. Biol. 15, 107–115 (2005).
Orban, T. I. & Izaurralde, E. Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 11, 459–469 (2005).
Souret, F. F., Kastenmayer, J. P. & Green, P. J. AtXRN4 degrades mRNA in Arabidopsis and its substrates include selected miRNA targets. Mol. Cell 15, 173–183 (2004).
Behm-Ansmant, I., Rehwinkel, J. & Izaurralde, E. miRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb. Symp. Quant. Biol. (in the press).
Wu, L., Fan, J. & Belasco, J. G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl Acad. Sci. USA 103, 4034–4039 (2006).
Giraldez, A. J. et al. Zebrafish miR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312, 75–79 (2006). References 57–59, together with reference 34, show that miRNAs accelerate the deadenylation of their targets.
Bagga, S. et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122, 553–563 (2005).
Liu, J., Valencia-Sanchez, M. A., Hannon, G. J. & Parker, R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature Cell Biol. 7, 719–723 (2005).
Liu, J. et al. A role for the P-body component GW182 in microRNA function. Nature Cell Biol. 7, 1261–1266 (2005).
Jakymiw, A. et al. Disruption of GW bodies impairs mammalian RNA interference. Nature Cell Biol. 7, 1267–1274 (2005).
Sen, G. L. & Blau, H. M. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nature Cell Biol. 7, 633–636 (2005).
Meister, G. et al. Identification of novel argonaute-associated proteins. Curr. Biol. 15, 2149–2155 (2005).
Ding, L., Spencer, A., Morita, K. & Han, M. The developmental timing regulator AIN-1 interacts with miRISCs and may target the Argonaute protein ALG-1 to cytoplasmic P bodies in C. elegans. Mol. Cell 19, 437–447 (2005).
Pillai, R. S. et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573–1576 (2005). References 61–67 describe the localization of AGO proteins and the accumulation of miRNAs and miRNA targets in P bodies.
Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I. & Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125, 1111–1124 (2006). Reports that translational repression of CAT-1 mRNA by miR-122 can be reversed under stress conditions by binding of the HuR protein in the 3′ UTR of this mRNA.
Pauley, K. M. et al. Formation of GW bodies is a consequence of microRNA genesis. EMBO Rep. 7, 904–910 (2006).
Wilczynska, A., Aigueperse, C., Kress, M., Dautry, F. & Weil, D. The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules. J. Cell Sci. 118, 981–992 (2005).
Anderson, P. & Kedersha, N. RNA granules. J. Cell Biol. 172, 803–808 (2006).
St Johnston, D. Moving messages: the intracellular localization of mRNAs. Nature Rev. Mol. Cell Biol. 6, 363–375 (2005).
Kimball, S. R., Horetsky, R. L., Ron, D., Jefferson, L. S. & Harding, H. P. Mammalian stress granules represent sites of accumulation of stalled translation initiation complexes. Am. J. Physiol. Cell Physiol. 284, C273–C284 (2003).
Kedersha, N. L., Gupta, M., Li, W., Miller, I. & Anderson, P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2α to the assembly of mammalian stress granules. J. Cell Biol. 147, 1431–1441 (1999).
Amiri, A. et al. An isoform of eIF4E is a component of germ granules and is required for spermatogenesis in C. elegans. Development 128, 3899–3912 (2001).
Nakamura, A., Amikura, R., Hanyu, K. & Kobayashi, S. Me31B silences translation of oocyte-localizing RNAs through the formation of cytoplasmic RNP complex during Drosophila oogenesis. Development 128, 3233–3242 (2001).
Navarro, R. E. & Blackwell, T. K. Requirement for P granules and meiosis for accumulation of the germline RNA helicase CGH-1. Genesis 42, 172–180 (2005).
Wilhelm, J. E. et al. Isolation of a ribonucleoprotein complex involved in mRNA localization in Drosophila oocytes. J. Cell Biol. 148, 427–439 (2000).
Audhya, A. et al. A complex containing the Sm protein CAR-1 and the RNA helicase CGH-1 is required for embryonic cytokinesis in Caenorhabditis elegans. J. Cell Biol. 171, 267–278 (2005).
Boag, P. R., Nakamura, A. & Blackwell, T. K. A conserved RNA–protein complex component involved in physiological germline apoptosis regulation in C. elegans. Development 132, 4975–4986 (2005).
St Johnston, D., Beuchle, D., Nusslein-Volhard, C. staufen, a gene required to localize maternal RNAs in the Drosophila egg. Cell 66, 51–63 (1991).
Thomas, M. G. et al. Staufen recruitment into stress granules does not affect early mRNA transport in oligodendrocytes. Mol. Biol. Cell 16, 405–420 (2005).
Lin, M. D., Fan, S. J., Hsu, W. S. & Chou, T. B. Drosophila decapping protein 1, dDcp1, is a component of the oskar mRNP complex and directs its posterior localization in the oocyte. Dev. Cell 10, 601–613 (2006).
Lall, S., Piano, F. & Davis, R. E. Caenorhabditis elegans decapping proteins: localization and functional analysis of Dcp1, Dcp2, and DcpS during embryogenesis. Mol. Biol. Cell 16, 5880–5890 (2005). References 83 and 84 show that the decapping enzyme DCP2 in C. elegans or the decapping co-activator DCP1 in D. melanogaster are components of polar granules.
Kotaja, N. et al. The chromatoid body of male germ cells: similarity with processing bodies and presence of Dicer and microRNA pathway components. Proc. Natl Acad. Sci. USA 103, 2647–2652 (2006).
Krichevsky, A. M. & Kosik, K. S. Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 32, 683–696 (2001).
Huang, Y. S., Carson, J. H., Barbarese, E. & Richter, J. D. Facilitation of dendritic mRNA transport by CPEB. Genes Dev. 17, 638–653 (2003).
Mallardo, M. et al. Isolation and characterization of Staufen-containing ribonucleoprotein particles from rat brain. Proc. Natl Acad. Sci. USA 100, 2100–2105 (2003).
Köhrmann, M. et al. Microtubule-dependent recruitment of Staufen–green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol. Cell. Biol. 10, 2945–2953 (1999).
Yoon, Y. J. & Mowry, K. L. Xenopus Staufen is a component of a ribonucleoprotein complex containing Vg1 RNA and kinesin. Development 131, 3035–3045 (2004).
Barreau, C., Paillard, L. & Osborne, H. B. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138–7150 (2005).
Chen, C. Y. et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107, 451–464 (2001).
Mukherjee, D. et al. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 21, 165–174 (2002).
Gherzi, R. et al. A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol. Cell 14, 571–583 (2004).
Lykke-Andersen, J. & Wagner, E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 19, 351–361 (2005).
Stoecklin, G., Mayo, T. & Anderson, P. ARE-mRNA degradation requires the 5′–3′ decay pathway. EMBO Rep. 7, 72–77 (2006). Together with reference 14, shows that ARE-mediated mRNA decay involves the enzymes required for general 5′→3′ mRNA degradation. Although ARE-binding proteins such as TTP localize to P bodies, ARE-containing mRNAs are nevertheless degraded in GW182-depleted cells that lack detectable P bodies.
Muhlrad, D., Decker, C. J. & Parker, R. Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5′→3′ digestion of the transcript. Genes Dev. 8, 855–866 (1994).
Vasudevan, S. & Peltz, S. W. Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae. Mol. Cell 7, 1191–1200 (2001).
Stoecklin, G. et al. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23, 1313–1324 (2004).
Jing, Q. et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120, 623–634 (2005). Shows that miRNAs contribute to the decay of ARE-containing mRNAs by facilitating the recruitment of TTP.
Minshall, N., Thom, G. & Standart, N. A conserved role of a DEAD box helicase in mRNA masking. RNA 7, 1728–1742 (2001).
Minshall, N. & Standart, N. The active form of Xp54 RNA helicase in translational repression is an RNA-mediated oligomer. Nucleic Acids Res. 32, 1325–1334 (2004).
Glavan, F., Behm-Ansmant, I., Izaurralde, E. & Conti, E. Structures of the PIN domains of SMG6 and SMG5 reveal a nuclease activity in the mRNA surveillance complex. EMBO Rep. 25, 5117–5125 (2006).
Jang, L. T., Buu, L. M. & Lee, F. J. Determinants of Rbp1p localization in specific cytoplasmic mRNA-processing foci, P-bodies. J. Biol. Chem. 281, 29379–29390 (2006).
Lotan, R. et al. The RNA polymerase II subunit Rpb4p mediates decay of a specific class of mRNAs. Genes Dev. 19, 3004–3016 (2005).
Segal, S. P., Dunckley, T. & Parker, R. Sbp1p affects translational repression and decapping in Saccharomyces cerevisiae. Mol. Cell. Biol. 26, 5120–5130 (2006).
Fierro-Monti, I. et al. Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E. J. Proteome Res. 5, 1367–1378 (2006).
Malys, N., McCarthy, J. E. Dcs2, a novel stress-induced modulator of m7GpppX pyrophosphatase activity that locates to P bodies. J. Mol. Biol. 363, 370–382 (2006).
Wichroski, M. J., Robb, G. B. & Rana, T. M. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog. 2, e41 (2006).
Mazroui, R. et al. Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum. Mol. Genet. 11, 3007–3017 (2002).
Kim, S. H., Dong, W. K., Weiler, I. J. & Greenough, W. T. Fragile X mental retardation protein shifts between polyribosomes and stress granules after neuronal injury by arsenite stress or in vivo hippocampal electrode insertion. J. Neurosci. 26, 2413–2418 (2006).
Rouhana, L. et al. Vertebrate GLD2 poly(A) polymerases in the germline and the brain. RNA 11, 1117–1130 (2005).
Breitwieser, W., Markussen, F. H., Horstmann, H. & Ephrussi, A. Oskar protein interaction with Vasa represents an essential step in polar granule assembly. Genes Dev. 10, 2179–2188 (1996).
Thomson, T. & Lasko, P. Drosophila tudor is essential for polar granule assembly and pole cell specification, but not for posterior patterning. Genesis 40, 164–170 (2004).
Wilsch-Brauninger, M., Schwarz, H. & Nusslein-Volhard, C. A sponge-like structure involved in the association and transport of maternal products during Drosophila oogenesis. J. Cell Biol. 139, 817–829 (1997).
Liang, L., Diehl-Jones, W. & Lasko, P. Localization of vasa protein to the Drosophila pole plasm is independent of its RNA-binding and helicase activities. Development 120, 1201–1211 (1994).
Findley, S. D., Tamanaha, M., Clegg, N. J. & Ruohola-Baker, H. Maelstrom, a Drosophila spindle-class gene, encodes a protein that colocalizes with Vasa and RDE1/AGO1 homolog, Aubergine, in nuage. Development 130, 859–871 (2003).
Lasko, P. F. & Ashburner, M. Posterior localization of vasa protein correlates with, but is not sufficient for, pole cell development. Genes Dev. 4, 905–921 (1990).
Harris, A. N. & Macdonald, P. M. aubergine encodes a Drosophila polar granule component required for pole cell formation and related to eIF2C. Development 128, 2823–2832 (2001).
Bardsley, A., McDonald, K. & Boswell, R. E. Distribution of tudor protein in the Drosophila embryo suggests separation of functions based on site of localization. Development 119, 207–219 (1993).
Snee, M. J. & Macdonald, P. M. Live imaging of nuage and polar granules: evidence against a precursor-product relationship and a novel role for Oskar in stabilization of polar granule components. J. Cell Sci. 117, 2109–2120 (2004).
Smart, F. M., Edelman, G. M. & Vanderklish, P. W. BDNF induces translocation of initiation factor 4E to mRNA granules: evidence for a role of synaptic microfilaments and integrins. Proc. Natl Acad. Sci. USA 100, 14403–14408 (2003).
Atlas, R., Behar, L., Elliott, E. & Ginzburg, I. The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J. Neurochem. 89, 613–626 (2004).
Acknowledgements
We are grateful to D.J. Thomas for comments on the manuscript. This study was supported by the Max Planck Society and the Human Frontier Science Program Organization (HFSPO). A.E. and I.B-A. are recipients of fellowships from the Portuguese Foundation for Science and Technology and the European Molecular Biology Organization (EMBO), respectively.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Glossary
- Ribonucleoprotein
-
(RNP). A complex of proteins and RNA. In many cases, the proteins bind directly to their cognate mRNA molecules (mRNPs). Proteins can also be recruited to the RNP particle through protein–protein interactions.
- 5′→3′ exoribonuclease
-
An enzyme that has an important role in all aspects of RNA metabolism. It degrades RNA to 5′ mononucleotides in a 5′→3′ direction.
- 5′-cap structure
-
A structure that consists of m7GpppN (where m7G represents 7-methylguanylate, p represents a phosphate group and N represents any base) that is located at the 5′ end of a eukaryotic mRNA.
- Decapping
-
The process of removing the 5′-cap structure from an mRNA, usually as a step prior to further 5′→3′-exonucleolytic digestion of the remainder of the mRNA. In eukaryotes, decapping is catalysed by the decapping enzyme DCP2 assisted by decapping co-activators such as DCP1, EDC3 and the LSm1–7 complex.
- Deadenylase
-
An enzyme that catalyses the degradation of the 3′-poly(A) tail, which is present on most eukaryotic mRNAs. Although many deadenylases have been described, the principal cytoplasmic activity in yeast seems to reside in the CCR4–CAF1–NOT complex.
- Exosome
-
A complex of at least 11 putative 3′→5′ exonucleases that functions in several different RNA-processing and RNA-degradation pathways in the nucleus and the cytoplasm.
- Nonsense-mediated mRNA decay
-
(NMD). The process by which the cell destroys mRNAs, the translation of which has been prematurely terminated owing to the presence of a nonsense codon within the coding region.
- Premature translation-termination codon
-
(PTC). An alternative name for a nonsense codon. An in-frame stop codon that terminates translation, which leads to C-terminal truncated proteins. PTCs elicit NMD.
- Small interfering RNA
-
(siRNA). A non-coding RNA of ∼22 nucleotides that is processed from a longer dsRNA during RNA interference. Such non-coding RNAs base pair with mRNA targets and confer target specificity on the silencing complexes in which they reside.
- microRNA
-
(miRNA). A small RNA of ∼22 nucleotides that is encoded by an endogenous gene. The miRNA regulates the expression of RNAs to which it is complementary in sequence.
- Argonaute proteins
-
A family of proteins that are characterized by the presence of two homology domains, PAZ and PIWI. These proteins are essential for diverse RNA-silencing pathways.
- RNA-induced silencing complex
-
(RISC). A complex that consists minimally of an Argonaute protein and the associated miRNA or siRNA. The RISC complex mediates miRNA- or siRNA-guided gene silencing.
- PIWI domain
-
A conserved protein domain that is found in members of the Argonaute-protein family. It is structurally similar to ribonuclease-H domains and, in at least some cases, has endoribonuclease activity.
- Polysome
-
Two or more ribosomes that are bound to different sites on the same mRNA.
- Nurse cell
-
An auxiliary cell that supplies the oocyte with synthesized mRNAs and proteins during insect oogenesis.
- Dicer
-
An RNase III-type nuclease that is required for the processing of double-stranded-RNA precursors into siRNAs.
- ARE-mediated mRNA decay
-
(AMD). A process of rapid degradation of mRNAs that harbour A- and U-rich sequence elements (AREs) that are generally located in the 3′-untranslated region of the mRNA.
Rights and permissions
About this article
Cite this article
Eulalio, A., Behm-Ansmant, I. & Izaurralde, E. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8, 9–22 (2007). https://doi.org/10.1038/nrm2080
Issue Date:
DOI: https://doi.org/10.1038/nrm2080